Twitter | Search | |
Search Refresh
Florent Petitprez Jan 15
“Soft-tissue sarcoma: to B or not to B” (we actually shortlisted this title) Our work on an immune classification of is now online . We notably show that B cells and tertiary lymphoid structures are associated with response to PD-1 blockade
Reply Retweet Like
Sarcoma Service at MSK Jul 28
We are excited to have Dr. Katherine Thornton join the Medical Oncology service . Dr. Thornton's experience in clinical trial development, FDA regulatory processes and young adult care will be invaluable to our patients.
Reply Retweet Like
Terry Fox Research Institute Jul 6
Treatments for primary have improved since Terry was diagnosed in 1977. But even today, little can be done if it spreads to other organs. That's why our researchers are looking for new ways to block metastasis and bring new hope to sarcoma patients
Reply Retweet Like
Nate Mesko Jul 30
Let’s celebrate Awareness Month. Skylar is 3yrs out from BKA for synovial sarcoma. An example of courage and perseverance. Something 98% of Americans with two legs would struggle doing. Proud to be part of your ride!
Reply Retweet Like
Go Team Anna Feb 11
Anna has now started her immunotherapy treatment in New York! We still need to fundraise to cover ongoing medical and living costs. Please keep sharing Anna's story and donate if you can.
Reply Retweet Like
Alessandro Gronchi Jul 29
A review about landmark articles in extremity is now online. Great job It was fun to work on this together!
Reply Retweet Like
Charlotte Betteridge Jul 2
3 years ago I hadn’t heard of , a form of cancer not many people are familiar with. I’ve experienced the reality, both the outstanding outcomes but also the devastation it can also cause. It’s - do your research & help reduce late diagnosis rates.
Reply Retweet Like
Aimee Crago, M.D. Jun 15
We are looking for a new post doc in our and lab. More info here:
Reply Retweet Like
Grünewald Lab Jul 15
Reply Retweet Like
Fox Chase Cancer Center Jun 11
Ripretinib was recently approved by the FDA, representing a new treatment option for patients with advanced GISTs. Fox Chase's Dr. Margaret von Mehren discusses the significance of this approval and what this could mean for some patients: .
Reply Retweet Like
Florent Petitprez Jan 20
[Thread 1/11] Alright, it's time for a about our recent article about the immune classification of soft-tissue and crucial role of B cells and tertiary lymphoid structures in .
Reply Retweet Like
Grünewald Lab Jun 29
🔥 MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of In Vivo 👇
Reply Retweet Like
Jessica Scarborough Jul 8
Hooray! I'm excited to share our published work here: Check out our thread below, which introduces each of the figures.
Reply Retweet Like
Sarcoma Sisters Jul 23
Excited to have Dr. Fitzhugh a pathologist on our podcast in September! Get inspired And read about her in the news!
Reply Retweet Like
Steve DeFroda May 21
ACL allograft.....plus some other things. Allograft reconstruction for proximal tibia osteosarcoma.
Reply Retweet Like
Sr CatherineWybourne Jun 3
Why doesn’t respond well to Research sponsored by SarcomaUK:
Reply Retweet Like
Lisa M Kopp, DO, MPH Jul 26
First combo run Study(COG and NRG) Adding pazopanib to neoadjuvant chemoradiation in children and adults with STS improved pathological response. Will have to wait a lil longer on survival outcomes!
Reply Retweet Like
Beth Thomas Jun 25
I posted this on IG a couple of days back so thought I’d share it here too, as I know I have a lot of wonderful followers who are currently going through treatment, are survivors or have family and friends who may relate. This is for you all. ❤️
Reply Retweet Like
Dr. Bui Pathologist🌼 Jul 27
Just published! Largest case series of a very rare . As the senior author & program director, I 🙏my fellowship team ⁦⁩ ⁦⁩ & collaborators ⁩ , Drs. Qiong & Yun ⁦⁩ ⁦
Reply Retweet Like
Atanas G. Atanasov Jun 9
RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma Other social media channels:
Reply Retweet Like